Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans.
about
Fibroblast growth factor signaling in skeletal development and diseaseSignaling mechanisms implicated in cranial sutures pathophysiology: CraniosynostosisAnalysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate.Unraveling the specificity of heparanase utilizing synthetic substrates.Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathwaysEmbryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells.Enzymatic placement of 6-O-sulfo groups in heparan sulfateDelayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogsEstrogen affects the glycosaminoglycan layer of the murine bladder.Mechanism of shortened bones in mucopolysaccharidosis VIIFGF/FGFR signaling in bone formation: progress and perspectives.Keratinocyte growth factor receptor: a therapeutic target in solid cancer.RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse CellsPingyangmycin and Bleomycin Share the Same Cytotoxicity Pathway.Research advances in Apert syndrome
P2860
Q26798215-264D3AB2-1516-465C-95A3-D12341657CBBQ28073737-CC15B5AE-6BA9-46E3-BC16-561364011CC8Q33664279-BFD9EFB4-570F-4575-A21D-BE906E5BDD56Q33824982-CFB380FC-C48C-48AA-8322-BA3BBD5E0093Q34003880-5A56FD9C-F185-4137-AF68-7361C1651E64Q34348632-6EF43FFE-9560-4590-8409-64F923FF7B09Q35230027-5AAD836F-975E-4232-B491-3AFF6BE98A27Q36269377-36D55625-8956-4B1F-BC0E-B4822514F0A9Q36940132-A854C398-A964-4CA9-9F72-2F851F904BB1Q37416992-E9CD3FD7-6AEA-47EB-AE84-994D33AED5C8Q37980181-F5F1015F-22DC-4B97-BE57-984F1E5FA7B8Q38551944-D2BFE432-6FC4-4D47-9E3D-BAFE72B280B5Q38712840-F3DC9266-66B8-48A0-8CC3-0ED99AF5D7D2Q38759996-62271EE3-3CA8-496C-B4A7-8FEDA5F6789FQ57920914-AB168333-9739-4BD8-8372-AEC42EF0286A
P2860
Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Inhibition or activation of Ap ...... y specific glycosaminoglycans.
@en
type
label
Inhibition or activation of Ap ...... y specific glycosaminoglycans.
@en
prefLabel
Inhibition or activation of Ap ...... y specific glycosaminoglycans.
@en
P2093
P2860
P356
P1476
Inhibition or activation of Ap ...... y specific glycosaminoglycans.
@en
P2093
Beth A Frazier
Daniel R Studelska
Jinghua Chen
Kari Giljum
Lijuan Zhang
Lynda M McDowell
P2860
P304
P356
10.1074/JBC.M512932200
P407
P577
2005-12-22T00:00:00Z